Swedish Orphan Biovitrum AB (FRA:B6E)
€ 23.86 -0.22 (-0.91%) Market Cap: 8.15 Bil Enterprise Value: 9.81 Bil PE Ratio: 42.61 PB Ratio: 2.56 GF Score: 89/100

Swedish Orphan Biovitrum AB (publ) Capital Markets Day Transcript

May 14, 2019 / 10:30AM GMT
Release Date Price: €15.29 (+7.24%)
Paula Treutiger;publ;Head of Communications;IR
Swedish Orphan Biovitrum AB

()-&

Apart from today's presenters from Sobi, we also have Dr. Dan Hart here with us that will give his perspective on hemophilia from a clinical perspective. And now I will hand over to Linda, who will goes through some practicalities.

Linda HolmstrÃ;m

¶ -

Yes. Hi, I'm Linda Holmström, and I work with corporate communications and the Investor Relations as well, together with Paula. Hopefully, we will not run into an emergency in here, but if we do, I need to inform you that we have emergency exits over here and over there. And may I also remind you to keep your mobile phones off. The presentations today will be recorded and will be available online tomorrow, sometime during the day. So therefore, if you would like to ask a question, we have colleagues that will be walking around with microphones, so please put the microphones close to your mouth so we can hear you loud and clear so everything will be recorded.

Today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot